Jianhua Chang

6.9k citations
164 papers · 2.0k indexed · 2 hit papers · h-index 21

Jianhua Chang

151 papers receiving 1.9k citations

Hit Papers

Pan-cancer efficacy of pralsetinib in patients wi...144201920262021202350100150200250

Peers

Jianhua Chang
Comparison fields: 5 of 122
  • Oncology 766
  • Pulmonary and Respiratory Medicine 615
  • Cancer Research 249
  • Instrumentation 32
  • Process Chemistry and Technology 21
Replace Lianjie Li with:
Lianjie Li China
Y. Niwa Japan
Jianjun Zhang China
Guolan Lu United States
Helmy Eltoukhy United States
Melvin A. Astrahan United States
Jonathan T. Yang United States
Sylvain Gioux United States
Clifford Hoyt United States
Xinyi Guo China
Jianhua Chang relative to Lianjie Li China Lianjie Li's profile →
Citations per field
00.5×5.3×
Lianjie Li · 1×
Citations per year

Countries citing papers authored by Jianhua Chang

Since Specialization
Citations

This map shows the geographic impact of Jianhua Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianhua Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianhua Chang more than expected).

Fields of papers citing papers by Jianhua Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianhua Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianhua Chang. The network helps show where Jianhua Chang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jianhua Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jianhua Chang Line = papers co-authored together Jianhua Chang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20245
4 20242
5 20242
6 20241
7 20240
8 20241
9 20242
10 20234
11 20232
12 20236
13 202319
14 20227
15 202220
16 20222
17 20212
18 202010
19 20198
20 20184

About Jianhua Chang

Jianhua Chang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Electronic, Optical and Magnetic Materials, having authored 164 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (38 papers), Photonic and Optical Devices (18 papers), Advanced Fiber Laser Technologies (17 papers), Lung Cancer Research Studies (15 papers), Plasmonic and Surface Plasmon Research (14 papers), Perovskite Materials and Applications (13 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Solid State Laser Technologies (11 papers). The work is most often cited by research in Oncology (766 citations), Pulmonary and Respiratory Medicine (615 citations) and Cancer Research (249 citations). Jianhua Chang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xianghua Wu, Hongxu Li, Jialei Wang, Hui Yu, Yi‐Long Wu, Haibin Ni, Caicun Zhou, Xiang Liu, Ying Cheng and Yu Gan. Their work appears in journals such as Nature Medicine, The Journal of Chemical Physics and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026